231 related articles for article (PubMed ID: 9252680)
61. Geranylgeranyl as well as farnesyl moiety is transferred to Ras p21 overproduced in adrenocortical cells transformed by c-Ha-rasEJ oncogene.
Osman H; Mazet JL; Maume G; Maume BF
Biochem Biophys Res Commun; 1997 Feb; 231(3):789-92. PubMed ID: 9070894
[TBL] [Abstract][Full Text] [Related]
62. The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents.
Ohkanda J; Blaskovich MA; Sebti SM; Hamilton AD
Prog Cell Cycle Res; 2003; 5():211-7. PubMed ID: 14593715
[TBL] [Abstract][Full Text] [Related]
63. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
64. Involvement of the alpha subunit of farnesyl-protein transferase in substrate recognition.
Pellicena P; Scholten JD; Zimmerman K; Creswell M; Huang CC; Miller WT
Biochemistry; 1996 Oct; 35(41):13494-500. PubMed ID: 8873619
[TBL] [Abstract][Full Text] [Related]
65. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
[TBL] [Abstract][Full Text] [Related]
66. Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth.
Omer CA; Anthony NJ; Buser-Doepner CA; Burkhardt AL; deSolms SJ; Dinsmore CJ; Gibbs JB; Hartman GD; Koblan KS; Lobell RB; Oliff A; Williams TM; Kohl NE
Biofactors; 1997; 6(3):359-66. PubMed ID: 9288406
[TBL] [Abstract][Full Text] [Related]
67. Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
Nagase T; Kawata S; Tamura S; Matsuda Y; Inui Y; Yamasaki E; Ishiguro H; Ito T; Miyagawa J; Mitsui H; Yamamoto K; Kinoshita M; Matsuzawa Y
Br J Cancer; 1997; 76(8):1001-10. PubMed ID: 9376258
[TBL] [Abstract][Full Text] [Related]
68. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors.
Whyte DB; Kirschmeier P; Hockenberry TN; Nunez-Oliva I; James L; Catino JJ; Bishop WR; Pai JK
J Biol Chem; 1997 May; 272(22):14459-64. PubMed ID: 9162087
[TBL] [Abstract][Full Text] [Related]
69. Photoaffinity-labeling peptide substrates for farnesyl-protein transferase and the intersubunit location of the active site.
Ying W; Sepp-Lorenzino L; Cai K; Aloise P; Coleman PS
J Biol Chem; 1994 Jan; 269(1):470-7. PubMed ID: 8276838
[TBL] [Abstract][Full Text] [Related]
70. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol.
Gelb MH; Tamanoi F; Yokoyama K; Ghomashchi F; Esson K; Gould MN
Cancer Lett; 1995 May; 91(2):169-75. PubMed ID: 7767906
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; Etiévant C; Hill B
Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
[TBL] [Abstract][Full Text] [Related]
72. Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis.
Singh SB; Zink DL; Williams M; Polishook JD; Sanchez M; Silverman KC; Lingham RB
Bioorg Med Chem Lett; 1998 Aug; 8(16):2071-6. PubMed ID: 9873488
[TBL] [Abstract][Full Text] [Related]
73. Identification of spinach farnesyl protein transferase. Dithiothreitol as an acceptor in vitro.
Parmryd I; Shipton CA; Swiezewska E; Andersson B; Dallner G
Eur J Biochem; 1995 Dec; 234(3):723-31. PubMed ID: 8575428
[TBL] [Abstract][Full Text] [Related]
74. Natural inhibitors for protein prenyltransferase.
Lee S; Park S; Oh JW; Yang C
Planta Med; 1998 May; 64(4):303-8. PubMed ID: 9619109
[TBL] [Abstract][Full Text] [Related]
75. [Farnesyl transferase inhibitors (anti-Ras). A new class of anticancer agents].
Levy R
Presse Med; 1995 Apr 15-22; 24(15):725-9. PubMed ID: 7784406
[TBL] [Abstract][Full Text] [Related]
76. Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs JB; Pompliano DL; Mosser SD; Rands E; Lingham RB; Singh SB; Scolnick EM; Kohl NE; Oliff A
J Biol Chem; 1993 Apr; 268(11):7617-20. PubMed ID: 8463291
[TBL] [Abstract][Full Text] [Related]
77. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
Kawata S; Nagase T; Yamasaki E; Ishiguro H; Matsuzawa Y
Br J Cancer; 1994 Jun; 69(6):1015-20. PubMed ID: 8198962
[TBL] [Abstract][Full Text] [Related]
78. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents.
Kohl NE; Conner MW; Gibbs JB; Graham SL; Hartman GD; Oliff A
J Cell Biochem Suppl; 1995; 22():145-50. PubMed ID: 8538192
[TBL] [Abstract][Full Text] [Related]
79. High-content assay to study protein prenylation.
Simonen M; Ibig-Rehm Y; Hofmann G; Zimmermann J; Albrecht G; Magnier M; Heidinger V; Gabriel D
J Biomol Screen; 2008 Jul; 13(6):456-67. PubMed ID: 18509097
[TBL] [Abstract][Full Text] [Related]
80. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo.
Broitman SA; Wilkinson J; Cerda S; Branch SK
Adv Exp Med Biol; 1996; 401():111-30. PubMed ID: 8886130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
